Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-HEP: Therapeutic vs Prophylactic Anticoagulation in COVID-19
NCT04345848Phase 3Terminated
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in coronavirus disease 2019 (COVID-19). Started Apr 2020; status: terminated.
02
Drugs
enoxaparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04345848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345848.